MICHAEL R MIGDEN to Drug Dosage Calculations
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Drug Dosage Calculations.
Connection Strength
0.044
-
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. J Immunother Cancer. 2020 06; 8(1).
Score: 0.044